Contact this trialFirst, we need to learn more about you.
Procedure
Meibomian Gland Probing for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
Recruiting1 award4 criteria
Boston, Massachusetts
This trial will study the effects of meibomian gland expression on people with SJS/TEN. The primary outcome is meibography, and the secondary outcome is patient symptoms. The investigators hypothesize that meibomian gland expression will improve symptoms in those patients.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service